Pharmacy Returns, The Total Solution
PharmaLink offers a wide array of returns processing options that cater to dispensing facilities across the complete spectrum of the pharmaceutical supply chain. With both off-site and on-site returns processing capabilities, our team of specialists will develop a program for your pharmacy that exceeds your expectations. With over 10 years of expertise in the industry, the level of automation we employ enables us to process returns at record breaking speeds while maintaining the highest level of accuracy. This benefits your pharmacy with faster disbursement of returns credits and a higher level of credit worthy product. We work with every pharmaceutical manufacturer in the industry to maintain the most comprehensive return policy and product pricing database.
All of our customers have access to an on-line return inventory system complete with return detail reports. Additionally, the level of customer service you will experience with PharmaLink adds to the total value of our services.
Return Preparation Training
In order to simplify the returns process and exceed the regulatory standards applicable to our industry, we developed the Prophet Web Inventory System to assist you in preparing returns. The system is easy to use and eliminates the need to handwrite inventory for returns ever again! This five minute video is a quick start guide to the PharmaLink return process and provides you with the following features:
|
|
Please take a few minutes to watch this video:
Industry News: Happening Now
-
Chance to Win an Apple iPad at APhA
To acknowledge pharmacists’ and pharmacy technicians’ efforts to set up their NABP...
-
NABP Supports Legislation Aimed to Protect Patients from Counterfeit Drugs and Fake Online Pharmacies
Association Issues Statement of Support for Online Pharmacy Safety Act of 2011
The...
-
Dosing Device Woes Lead to Tylenol RecallMcNeil Consumer Healthcare today announced the recall of 574,000 bottles of Infants'...
-
"Universal influenza vaccine" demonstrates success in Phase II trialBiondVax Pharmaceuticals Ltd. announces that its Multimeric-001 vaccine was found to be...
-
Bedford Recalls Cytarabine 1-g VialsBedford Laboratories today announced a recall of three lots of cytarabine for...


